Navigation Links
InnoPack Pharma Confex to Focus on Innovation in Packaging for Compliance and Safety
Date:4/11/2013

MUMBAI, India, April 12, 2013 /PRNewswire/ --

The 2nd edition of InnoPack Pharma taking place from 27-28 June 2013, in MumbaiIndia will gather over 150 packaging professionals and around 30 exhibitors to the confex which is dedicated to pharmaceutical packaging and drug delivery systems.

One of a kind in the Indian healthcare industry, InnoPack India continues to differentiate itself through its high-quality audience and positioning on technological innovations in packaging and delivery systems for pharmaceutical products. "InnoPack provides a platform with good opportunities to network and discuss critical packaging issues," says Ulrike Kreysa , Vice President Healthcare, GS1 Global.

For all the pharma packaging professionals, the 2013 edition will offer many new features in terms of conference topics, networking formats and an exhibition area. This year, as a new approach, InnoPack India will focus on innovation in pharma packaging for compliance and safety. This topic has been chosen as the guiding principle by the strategic advisory board comprising of Gautam Buddha, Senior Director Packaging Development, Dr Reddy's Laboratory; Santanu Chowdhury , Associate Director Packaging Development; Ranbaxy and Rajesh Mishra , General Manager Packaging Development, Abbott to reflect on the important role played by compliance in the development of drug delivery systems and pharmaceutical packaging in order to create innovative solutions improving patient compliance. All the while, changes in regulatory requirements, the need to optimise manufacturing processes, cost reduction and sustainable development must be taken into account.

At the conference, a panel of international experts including Tassilo Korab , Director, Healthcare Com
'/>"/>

SOURCE UBM India
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Americas Biopharmaceutical Companies Commitment to Research Remains Strong Despite Challenges
2. Omthera Pharmaceuticals, Inc. Announces Pricing of Initial Public Offering
3. PharmaFocus: Vaccine Adjuvants in Infectious Disease
4. Pharmacyclics Triggers Fourth Milestone Payment for Enrollment of 5th Patient in Frontline Phase III CLL Study
5. Pharmagen Laboratories Remains Industry Leader on Patient Safety
6. WuXi PharmaTech Schedules First-Quarter 2013 Earnings Release
7. 2013 Chinese Pharmaceutical Guidebook: Drug Registration Rules
8. PharmaPoint: Osteoporosis - US Drug Forecast and Market Analysis to 2022
9. Merrimack Pharmaceuticals Preclinical Research Shows MM-111 Restores Sensitivity To Chemotherapy And HER2-targeted Treatment In Gastric Cancer Model
10. Inovio Pharmaceuticals & U.S. Army Receive $3.5 Million Biodefense Grant to Further Develop Mass Vaccination Device
11. PharmaPoint: Osteoporosis - India Drug Forecast and Market Analysis to 2022
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... BRUSSELS , Sept. 1, 2015 /PRNewswire/ ... Brussels: UCB) today announced top-line results from the ... with Teriparatide in postmenopaUsal women with osteoporosis at ... therapy). The study (NCT01796301) met the primary endpoint, ... romosozumab in the percent change of total hip ...
(Date:9/1/2015)... WAYNE, N.J. , Sept. 1, 2015 ... II CS-7s Computed Radiography (CR) system, designed to deliver ... practices. By utilizing the same Control Station as the ... is assured with an upgrade path from CR to ... patient imaging to help improve workflow with unparalleled reliability ...
(Date:9/1/2015)... UT Southwestern Medical Center President Dr. Daniel K. ... Michael C. Burgess , M.D., and Joe ... st Century Cures Act, bipartisan legislation in support ... the United States Senate. UT ... department chairs, center directors, and leading researchers – joined ...
Breaking Medicine Technology:Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 2Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 3Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 4Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 5Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 6Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 7Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 8Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 9Konica Minolta Launches New CR System with Low-Cost Upgrade Path to DR 2U.S. Rep. Michael C. Burgess, M.D., hosts roundtable at UT Southwestern to discuss pivotal 21st Century Cures Act and future of biomedical science 2U.S. Rep. Michael C. Burgess, M.D., hosts roundtable at UT Southwestern to discuss pivotal 21st Century Cures Act and future of biomedical science 3U.S. Rep. Michael C. Burgess, M.D., hosts roundtable at UT Southwestern to discuss pivotal 21st Century Cures Act and future of biomedical science 4U.S. Rep. Michael C. Burgess, M.D., hosts roundtable at UT Southwestern to discuss pivotal 21st Century Cures Act and future of biomedical science 5
... a primary biliary cirrhosis patient,has the biomarker of ... Mayo Clinic,researchers have found that first-degree relatives (i.e., ... (PBC) are,more likely to have the biomarker of ... information, physicians could screen and assess first-degree,relatives of ...
... Va., Sept. 10 The following letter is,being released ... shareholders: Dear Fellow Shareholders: The past 12 ... The U.S. Food and Drug Administration (FDA) granted us ... trial with our cancer drug,Multikine(R) and also granted Multikine ...
Cached Medicine Technology:New Research May Lead to Earlier Diagnosis and Treatment of Primary Biliary Cirrhosis in Families 2CEL-SCI Corporation Releases Letter to Shareholders 2CEL-SCI Corporation Releases Letter to Shareholders 3CEL-SCI Corporation Releases Letter to Shareholders 4CEL-SCI Corporation Releases Letter to Shareholders 5
(Date:9/2/2015)... ... September 02, 2015 , ... Canopy Partners, a ... to the Inc. 5000 List, an independent ranking of the fastest- growing ... years, and this achievement puts Canopy in rarefied company. Over the years, this ...
(Date:9/2/2015)... ... September 02, 2015 , ... Traveling to the Caribbean can be ... magnificent flora and fauna. , Lifestyle Holidays Vacation Club knows that ... make travelers experience that much better, Lifestyle Holidays Vacation Club has put together its ...
(Date:9/1/2015)... ... September 01, 2015 , ... September is National Prostate Cancer ... affects more than 233,000 men each year in the United States. , Prostate cancer ... non-skin cancer in America, affecting 1 in 7 men. One new case occurs every ...
(Date:9/1/2015)... ... 2015 , ... Earth Brands, ( http://www.earthbrands.com ) a comfort-meets-fashion ... who buys an Earth Brand shoe will be given an opportunity to plant ... Future, a nonprofit dedicated to planting more trees. Earth Brands products represent contemporary ...
(Date:9/1/2015)... ... September 01, 2015 , ... Stress comes ... created from everyday life changes can lead to very serious, life-altering events. Fortunately ... coping with stress. Herbal supplement manufacturer MediHerb has coupled therapeutic doses ...
Breaking Medicine News(10 mins):Health News:Canopy Partners Named to 2015 Inc. 5000 Fastest Growing Companies List 2Health News:Lifestyle Holidays Vacation Club Lists 3 Things to Consider When On a Puerto Plata Vacation 2Health News:Lifestyle Holidays Vacation Club Lists 3 Things to Consider When On a Puerto Plata Vacation 3Health News:September is Prostate Cancer Awareness Month 2Health News:September is Prostate Cancer Awareness Month 3Health News:Earth Brands Footwear Partners with Trees for the Future for Launch of Fall Collection: Buy Shoes, Plant a Tree 2Health News:Earth Brands Footwear Partners with Trees for the Future for Launch of Fall Collection: Buy Shoes, Plant a Tree 3Health News:MediHerb Launches New Herbal Supplement to Help with the Challenges of Everyday Life 2Health News:MediHerb Launches New Herbal Supplement to Help with the Challenges of Everyday Life 3
... say finding suggests alternate vision routes in the brain , , ... of second sight: Scientists report that a blind man in ... even though he has no conscious sensation of seeing the ... that the human brain has ways of processing vision beyond ...
... patients with autoimmune diseases like lupus and rheumatoid arthritis ... too, according to a new report in the ... these cells are maintained in an ,off, state, perhaps ... true predecessors of the self-attacking cells prevalent in lupus ...
... woes ratchet up mental health problems already more common this ... --Sagging spirits, sagging economy. , That,s the holidays this ... -- the usual melancholy compounded by the highest jobless rate ... "Mental health problems are common and spike more often during ...
... Eve , ... Terre Haute, Ind. (PRWEB) December 22, 2008 -- Fleschner, Stark, Tanoos ... provide free transportation to those who can,t drive or feel they don,t have ... Cab Ride Home program will be available from 10 p.m. on Wednesday, December ...
... two proteins which work in tandem in the brain,s blood ... do the proteins lessen blood flow in the brain, but ... able to remove amyloid beta, the protein that builds up ... disease. , The work, described in a paper published online ...
... pressures can be overcome with honest approach to food, ... The holiday season can be especially difficult for overweight ... eating habits and cope with widely held misconceptions, according ... people feel self-conscious about what they wear and what ...
Cached Medicine News:Health News:'Blind' Man Navigates Obstacle Course Without Error 2Health News:Potential autoimmunity-inducing cells found in healthy adults 2Health News:Blue and Broke for the Holidays 2Health News:Blue and Broke for the Holidays 3Health News:Blue and Broke for the Holidays 4Health News:Fleschner, Stark, Tanoos & Newlin to Offer Free Terre Haute Cab Rides on New Year's Eve 2Health News:Fleschner, Stark, Tanoos & Newlin to Offer Free Terre Haute Cab Rides on New Year's Eve 3Health News:Two cardiovascular proteins pose a double whammy in Alzheimer's 2Health News:Two cardiovascular proteins pose a double whammy in Alzheimer's 3Health News:Two cardiovascular proteins pose a double whammy in Alzheimer's 4Health News:For the Obese, Holiday Tables Serve Platefuls of Doubt 2
The removable inflation/injection adapter allows the cystoscope to be removed after the catheter is in place. Supplied sterile in peel-open packages. Intended for one-time use....
Gold radiopaque markers indicate the proximal and distal ends of the balloon. Supplied sterile in peel-open packages. Intended for one-time use....
... The tipless balloon design allows the ureter ... A radiopaque marker at the base of ... extent of ureteral dilation. Supplied sterile in ... includes:, Pin Vise Handle (plastic), Straight Safety ...
Used retrograde to dilate the ureter and establish a conduit for a flexible ureteroscope. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: